X

    Xtant Medical Holdings Inc (XTNT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • AMEX

    $0.39
    +0.00 (+1.22%)

    Market Cap: $53.87M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    61%(20/33)
    Avg Surprise
    -26.56%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.01
    Range$-0.02 - $0.00
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$-0.01+0.0%
    7d ago$-0.01+0.0%
    Current$-0.01
    Revenue Consensus
    $27M
    Range$27M - $27M
    2 analysts
    Dec 31, 2026
    EPS Consensus$-0.07
    Range$-0.07 - $-0.06
    2 analysts
    Revenue Consensus
    $29M
    Range$28M - $29M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.07---
    Sep 26EST
    		-$-0.01---
    Jun 26
    		$-0.07$-0.02-250.00%Miss-333.3%
    Mar 26
    		$-0.02$-0.02+0.00%Beat-300.0%
    Dec 25
    		$-0.01$-0.01-182.00%Miss-5.2%
    Sep 25
    		$0.01$-0.01+200.00%Beat+125.0%
    Jun 25
    		$0.03$-0.02+250.00%Beat+250.0%
    Mar 25
    		$0.01$-0.01+200.00%Beat+150.0%
    Dec 24
    		$-0.01$-0.02+33.00%Beat+55.3%
    Sep 24
    		$-0.04$-0.02-100.00%Miss-157.1%
    Jun 24
    		$-0.02$-0.02+0.00%Beat+0.0%
    Mar 24
    		$-0.02$-0.02+0.00%Beat+0.0%
    Dec 23
    		$-0.03$-0.02-50.00%Miss-50.0%
    Sep 23
    		$0.07$-0.01+800.00%Beat+333.3%
    Jun 23
    		$-0.02$-0.02+0.00%Beat+0.0%
    Mar 23
    		$-0.02$-0.03+33.33%Beat+33.3%
    Dec 22
    		$-0.02$-0.02+0.00%Beat+33.3%
    Sep 22
    		$-0.03N/AN/ABeat-50.0%
    Jun 22
    		$-0.02N/AN/ABeat-100.0%
    Mar 22
    		$-0.03N/AN/ABeat-252.9%
    Dec 21
    		$-0.03$-0.03+0.00%Beat-200.0%
    Sep 21
    		$-0.02N/AN/ABeat+80.0%
    Jun 21
    		$-0.01N/AN/ABeat+94.7%
    Mar 21
    		$-0.01$0.00N/ABeat+95.5%
    Dec 20
    		$-0.01N/A+91.67%Beat+91.7%
    Sep 20
    		$-0.10$-0.11+9.09%Beat+28.6%
    Jun 20
    		$-0.19$-0.11-72.73%Miss-26.7%
    Mar 20
    		$-0.19$0.00N/ABeat+9.5%
    Dec 19
    		$-0.12$-0.21+42.86%Beat+47.8%
    Sep 19
    		$-0.14$-0.28+50.00%Beat+41.7%
    Jun 19
    		$-0.15N/A+71.15%Beat+60.5%
    Mar 19
    		$-0.21$-0.36+41.67%Beat+61.1%
    Dec 18
    		$-0.23$-0.32+28.13%Beat+98.8%
    Sep 18
    		$-0.24$-0.19-26.32%Miss+95.7%
    Jun 18
    		$-0.38$-0.27-40.74%Miss+93.9%
    Mar 18
    		$-0.54$-0.38-42.11%Miss+84.5%
    Dec 17
    		$-18.77$-3.49-437.82%Miss-468.8%
    Sep 17
    		$-5.64$-0.48-1075.00%Miss-30.9%
    Jun 17
    		$-6.18$-1.20-415.00%Miss-
    Mar 17
    		$-3.48$-3.54+1.69%Beat-
    Dec 16
    		$-3.30$-2.64-25.00%Miss-
    Sep 16
    		$-4.31$-3.84-12.24%Miss-

    Key Metrics

    Valuation
    P/E Ratio-4.13EV/EBITDA5.57x
    Price/FCF-78.33xFCF Yield-1.28%
    Profitability
    Profit Margin-10.20%Operating Margin-18.10%
    ROE-25.20%ROIC16.79%
    Financial Health
    Debt/Equity0.57xInterest Coverage2.88x
    Current Ratio2.16xQuick Ratio1.05x
    Trading Statistics
    Beta-0.14Avg Volume4.31M
    52-Week High$0.9552-Week Low$0.27

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.34
    SMA 20$0.36
    SMA 50$0.40
    SMA 200$0.54
    EMA 10$0.35
    EMA 20$0.36
    EMA 50$0.40
    EMA 200$0.50

    MACD

    Line: -0.02Signal: -0.02Hist: 0.01

    ADX

    ADX: 18.4+DI: 37.6-DI: 14.3

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down48.0
    PSAR$0.30

    Bollinger Bands

    Upper Band$0.47
    Lower Band$0.25
    %B Position5951%(Upper)
    Band Width0.64

    RSI (14-Day)

    Neutral
    56.0

    Momentum Oscillators

    Stoch %K47.0
    Stoch %D38.2
    Williams %R-45.1
    ROC (10d)17.3%
    Momentum0.06
    CCI (20d)33.5
    MFI (14d)95.9

    Volatility Measures

    ATR (14d)$0.04(10.9%)
    StdDev (20d)0.05
    Hist Vol124.8%(High)

    Volume Flow

    VWAP$0.38
    OBV94.4M
    AD Line-48.0M
    CMF (20d)-0.370

    Volume Metrics

    Avg Vol (20d)4.5M
    Vol Ratio0.6x
    VWMA (20d)$0.38

    Pivot Points

    R3$0.61
    R2$0.55
    R1$0.47
    Pivot Point$0.40
    S1$0.32
    S2$0.26
    S3$0.17

    Advanced Oscillators

    TSI-21.92
    Ultimate Osc40.9
    KST-207.36

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$23.03M$20.88M$32.36M$33.26M$35.41M$32.90M$31.51M$27.94M$29.94M$27.87M$28.11M$25.02M
    Cost of Revenue$9.70M$8.91M$14.60M$11.26M$11.13M$12.66M$15.49M$11.63M$11.36M$10.57M$10.97M$9.69M
    Gross Profit$13.33M$11.97M$17.75M$21.99M$24.28M$20.24M$16.02M$16.31M$18.58M$17.30M$17.14M$15.33M
    Operating Expenses$22.50M$14.89M$18.70M$19.45M$19.66M$19.18M$17.91M$20.08M$21.53M$20.77M$20.94M$18.72M
    R&D$695,000$435,000$459,000$634,000$566,000$443,000$521,000$701,000$636,000$527,000$492,000$490,000
    SG&A$6.44M$6.27M$7.29M$7.07M$7.48M$7.53M$5.70M$7.49M$7.71M$7.79M$8.87M$7.14M
    Operating Income$-9,169,000$-2,923,000$-944,000$2.54M$4.62M$1.06M$-1,881,000$-3,777,000$-2,946,000$-3,470,000$-3,806,000$-3,385,000
    Interest Income$1,000$219,000$0$0$0$0$0$0$0$0$15,000$48,000
    Interest Expense$542,000$599,000$718,000$904,000$1.00M$1.04M$1.13M$1.20M$992,000$835,000$817,000$760,000
    Income Before Tax$-9,340,000$-3,062,000$1.60M$1.56M$3.81M$33,000$-3,143,000$-4,962,000$-3,825,000$-4,332,000$-3,726,000$6.93M
    Income Tax Expense$73,000$27,000$1.54M$257,000$255,000$-25,000$21,000$62,000$36,000$68,000$577,000$-2,300,000
    Net Income$-9,413,000$-3,089,000$57,000$1.31M$3.55M$58,000$-3,164,000$-5,024,000$-3,861,000$-4,400,000$-4,303,000$9.23M
    EBITDA$-8,291,000$-2,148,000$4.04M$3.63M$5.98M$2.15M$-873,000$-2,717,000$-1,835,000$-2,453,000$-1,907,000$8.53M
    EBIT$-8,799,000$-2,682,000$2.22M$2.47M$4.81M$1.08M$-2,021,000$-3,790,000$-2,833,000$-3,458,000$-2,924,000$7.64M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about XTNT

    News

    ETFs Investing in Xtant Medical Holdings, Inc. Stocks

    This article lists ETFs that hold Xtant Medical Holdings, Inc. stocks, providing details such as market value, weight, issuer, management style, expense ratio, AUM, price, and performance. It highlights the BUSM EA Bridgeway Ultra-Small Company Market ETF as one such fund, making investing in these stocks more accessible with lower risk. The information aims to help investors identify funds with exposure to Xtant Medical Holdings.

    TradingView•8/20/26•
    Neutral

    Xtant Medical (XTNT) insider updates SEC on stock transaction

    Jonn R. Beeson, a Director at Xtant Medical Holdings, Inc. (XTNT), updated his stock holdings in a recent Form 4 filing with the SEC. The filing indicates a net acquisition of 215,517 shares, primarily through a deferred stock unit (DSU) award that will vest in August 2027. Beeson now holds a significant number of shares both directly and indirectly through a trust.

    Stock Titan•8/19/26•
    Neutral

    Xtant Medical (XTNT) insider reports new stock transaction

    Xtant Medical Holdings, Inc. (XTNT) director Tyler Lipschultz reported a new stock transaction via a Form 4 filing, acquiring 215,517 shares of common stock through a restricted stock unit (RSU) award. These shares will vest on August 15, 2027, provided Lipschultz remains a director. After this transaction, his direct holdings amount to 373,745 shares.

    Stock Titan•8/19/26•
    Neutral

    Xtant Medical (XTNT) grants COO 450K DSUs vesting 2027–30

    Xtant Medical (XTNT) has granted its Chief Operating Officer, Mark A. Schallenberger, 450,000 deferred stock units (DSUs). These DSUs will vest in four equal installments annually from 2027 through 2030, conditional on his continued employment. Additionally, 7,070 shares were withheld for tax obligations related to previously vested restricted stock units.

    Stock Titan•8/18/26•
    Neutral

    Xtant Medical Q2 2026 Earnings: Revenue Declines as Margins Contract

    Xtant Medical Holdings reported a significant decline in Q2 2026 revenue, falling to $23.0 million, primarily due to asset divestitures and the loss of high-margin license income. The company swung to a diluted EPS loss of $0.07 and negative adjusted EBITDA, while gross margin contracted notably. Xtant Medical also lowered its full-year 2026 revenue guidance, citing continued headwinds and underperforming biologics revenue.

    TradingKey•8/12/26•
    Bearish

    Frequently Asked Questions About XTNT

    Does XTNT pay dividends?
    Xtant Medical Holdings Inc (XTNT) does not currently pay a regular dividend.
    What is XTNT's market cap?
    Xtant Medical Holdings Inc (XTNT) has a market capitalization of $53.87M with a current stock price of $0.39.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In